Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement-Reference-Cited by-同舟云学术

Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement

Published:2023-10 Issue: Volume:Volume 18 Page:2225-2243
ISSN:1178-2005
Container-title:International Journal of Chronic Obstructive Pulmonary Disease
language:en
Short-container-title:COPD

Author:

Manzetti Gian Marco^ORCID,Ora Josuel^ORCID,Sepiacci Arianna,Cazzola Mario^ORCID,Rogliani Paola^ORCID,Calzetta Luigino^ORCID

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pulmonary and Respiratory Medicine,General Medicine

Reference63 articles.

1. 2023 GOLD report - global initiative for chronic obstructive lung disease - GOLD. Available from: https://goldcopd.org/2023-gold-report-2/. Accessed April 14, 2023.

2. Prevention of clinically important deteriorations in COPD with umeclidinium/vilanterol

3. Clinically important deterioration: a composite tool for managing patients with COPD

4. Psychological interventions for adults with asthma: A systematic review

5. Measuring disease activity in COPD: is clinically important deterioration the answer?

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A commentary on “Moderate and severe exacerbations have a significant impact on health-related quality of life, utility, and lung function in patients with chronic obstructive pulmonary disease: A meta-analysis”;International Journal of Surgery;2024-04-11

2. The novel inhaled dual PDE3 and PDE4 inhibitor ensifentrine for the treatment of COPD: A systematic review and meta-analysis protocol on trough FEV1 and exacerbation according to PRISMA statement;Current Research in Pharmacology and Drug Discovery;2024